RxDoctor Payments Data

Thomas Birch

Teaneck, NJNPI 1447342647

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Abbott.

$22in general payments, 2019–2025

Across 1 payment — averaging $22.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$22
$401,745in research payments, 2019–2025

Across 142 payments — averaging $2829.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • CSL Behring$176K
  • Novo Nordisk AS$143K
  • Incyte Corporation$32K
  • Sanofi Pasteur Inc.$25K
  • EMD Serono, Inc.$21K
  • Stryker$2K
  • plus $2K from 2 others

What the payments were for

  • Food & beverage$22100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott1$22

Where these figures come from

Is this you, or does something look wrong? →